National Health (Weighted average disclosed price – October 2019 reduction day) Amendment Determination 2019 (PB 75 of 2019) (Cth)

PB 75 of 2019

National Health (Weighted average disclosed price – October 2019 reduction day) Amendment Determination 2019

National Health Act 1953

I, ADRIANA PLATONA, First Assistant Secretary, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 99ADB(4) of the National Health Act 1953.

Dated:   15 August 2019

ADRIANA PLATONA

First Assistant Secretary

Technology Assessment and Access Division

Department of Health

1. Name of Instrument

(1)     This instrument is the National Health (Weighted average disclosed price – October 2019 reduction day) Amendment Determination 2019.

(2)     This instrument may also be cited as PB 75 of 2019.

1. Commencement

This instrument commences on the day after it is registered.

1. Amendments to PB 45 of 2019

This instrument amends the National Health (Weighted average disclosed price – October 2019 reduction day) Determination 2019 (PB 45 of 2019).

Schedule 1     Amendments

[1]     Schedule 1

omit:

5	Bivalirudin	Powder for I.V. injection 250 mg (as trifluoroacetate)	Injection	Angiomax	417.93
6	Bivalirudin	Powder for I.V. injection 250 mg (as trifluoroacetate)	Injection	Bivalirudin APOTEX	417.93

[2]     Schedule 1

omit:

44	Epirubicin	Solution for injection containing epirubicin hydrochloride 100 mg in 50 mL	Injection/Intravesical	Epirubicin ACT	18.07
45	Epirubicin	Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL	Injection/Intravesical	Epirube	36.14
46	Epirubicin	Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL	Injection/Intravesical	Epirubicin Accord	36.14
47	Epirubicin	Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL	Injection/Intravesical	Epirubicin ACT	36.14
48	Epirubicin	Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL	Injection/Intravesical	Pharmorubicin	36.14
49	Epirubicin	Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL	Injection/Intravesical	Epirube	9.04
50	Epirubicin	Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL	Injection/Intravesical	Epirubicin ACT	9.04
51	Epirubicin	Solution for injection containing epirubicin hydrochloride 50 mg in 25 mL	Injection/Intravesical	Pharmorubicin	9.04

[3]     Schedule 1

omit:

99	Ivabradine	Tablet 5 mg (as hydrochloride)	Oral	APO-Ivabradine	27.32
100	Ivabradine	Tablet 5 mg (as hydrochloride)	Oral	Coralan	27.32
101	Ivabradine	Tablet 7.5 mg (as hydrochloride)	Oral	APO-Ivabradine	27.32
102	Ivabradine	Tablet 7.5 mg (as hydrochloride)	Oral	Coralan	27.32

[4]     Schedule 1

omit:

113	Pemetrexed	Powder for I.V. infusion 1 g (as disodium)	Injection	DBL Pemetrexed	51.92
114	Pemetrexed	Powder for I.V. infusion 1 g (as disodium)	Injection	Pemetrexed Accord	51.92
115	Pemetrexed	Powder for I.V. infusion 100 mg (as disodium)	Injection	Alimta	5.19
116	Pemetrexed	Powder for I.V. infusion 100 mg (as disodium)	Injection	DBL Pemetrexed	5.19
117	Pemetrexed	Powder for I.V. infusion 100 mg (as disodium)	Injection	Pemetrexed Accord	5.19
118	Pemetrexed	Powder for I.V. infusion 100 mg (as disodium)	Injection	PEMETREXED-DRLA	5.19
119	Pemetrexed	Powder for I.V. infusion 100 mg (as disodium)	Injection	Reladdin	5.19
120	Pemetrexed	Powder for I.V. infusion 100 mg (as disodium)	Injection	Tevatrexed	5.19
121	Pemetrexed	Powder for I.V. infusion 500 mg (as disodium)	Injection	Alimta	25.96
122	Pemetrexed	Powder for I.V. infusion 500 mg (as disodium)	Injection	DBL Pemetrexed	25.96
123	Pemetrexed	Powder for I.V. infusion 500 mg (as disodium)	Injection	Pemetrexed Accord	25.96
124	Pemetrexed	Powder for I.V. infusion 500 mg (as disodium)	Injection	Pemetrexed APOTEX	25.96
125	Pemetrexed	Powder for I.V. infusion 500 mg (as disodium)	Injection	Pemetrexed DRLA	25.96
126	Pemetrexed	Powder for I.V. infusion 500 mg (as disodium)	Injection	Reladdin	25.96
127	Pemetrexed	Powder for I.V. infusion 500 mg (as disodium)	Injection	Tevatrexed	25.96

Schedule 2     Amendments

[5]     Schedule 2

after:

485 Bisoprolol Tablet containing bisoprolol fumarate 5 mg Oral Terry White Chemists Bisoprolol 6.49

insert:

485A	Bivalirudin	Powder for I.V. injection 250 mg (as trifluoroacetate)	Injection	Angiomax	474.81
485B	Bivalirudin	Powder for I.V. injection 250 mg (as trifluoroacetate)	Injection	Bivalirudin APOTEX	474.81

[6]     Schedule 2

after:

1766 Isosorbide mononitrate Tablet 60 mg (sustained release) Oral Terry White Chemists Isosorbide Mononitrate 3.29

insert:

1766A Isotretinoin Capsule 5 mg Oral Oratane 11.01

[7]     Schedule 2

after:

1785 Itraconazole Capsule 50 mg Oral Lozanoc 101.95

insert:

1785A	Ivabradine	Tablet 5 mg (as hydrochloride)	Oral	APO-Ivabradine	31.03
1785B	Ivabradine	Tablet 5 mg (as hydrochloride)	Oral	Coralan	31.03
1785C	Ivabradine	Tablet 7.5 mg (as hydrochloride)	Oral	APO-Ivabradine	31.03
1785D	Ivabradine	Tablet 7.5 mg (as hydrochloride)	Oral	Coralan	31.03